A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Clinical trial NCT01121731 · COMPLETED

Trial details

NCT number: NCT01121731
Sponsor: Digna Biotech S.L.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C Virus Infection Genotype 1 Treatment-Experienced Patients Relapses

Start date: 2010-05-01
Primary completion: 2012-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.